| 英文名 | Methyl N2-[(4-methylphenyl)sulfonyl]-N5-(2,6,10,14-tetraoxo-1,15-diphenyl-3,5,11,13-tetraoxa-7,9-diazapentadecan-8-ylidene)-L-ornithinate |
|---|---|
| 英文别名 |
(2S)-2-[[(4-methylphenyl)sulfonyl]amino]-9,13-dioxo-14-phenyl-7-[[[[(2-phenylacetyl)oxy]methoxy]carbonyl]amino]-10,12-dioxa-6,8-diazatetradec-6-enoicacid,methylester
pro-Tosyl-L-ginine Methyl Ester 10,12-Dioxa-6,8-diazatetradec-6-enoic acid, 2-[[(4-methylphenyl)sulfonyl]amino]-9,13-dioxo-14-phenyl-7-[[[[(2-phenylacetyl)oxy]methoxy]carbonyl]amino]-, methyl ester, (2S) L-Ornithine, N5-[bis[[[[(2-phenylacetyl)oxy]methoxy]carbonyl]amino]methylene]-N2-[(4-methylphenyl)sulfonyl]-, methyl ester |
| 描述 | proTAME是TAME的细胞渗透性前药,是一种后期促进复合物/环状体(APC/C)抑制剂,与APC结合优先抑制APC/C(Cdc20);阻止细胞中期而不扰乱纺锤体,但依赖于主轴装配检查点(SAC);与化学治疗剂联合有效靶向体外骨肉瘤。 |
|---|---|
| 参考文献 | References 1. Zeng X, et al. Cancer Cell. 2010 Oct 19;18(4):382-95. 2. Giovinazzi S, et al. Cell Cycle. 2013 Aug 15;12(16):2598-607. 3. Hu K, et al. Oncotarget. 2014 May 30;5(10):3088-100. View Related Products by Target E3 Ubiquitin Ligase |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 分子式 | C34H38N4O12S |
| 分子量 | 726.750 |
| 精确质量 | 726.220703 |
| LogP | 6.05 |
| 折射率 | 1.587 |